ArticleScientific reports2025
Oocyte and embryo developmental competence following small multiple cyclophosphamide dose administrations in prepubertal female mice are comparable to adolescents.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A small multiple-dose regimen of cyclophosphamide (CY) compared to a large single dose in prepubertal mice has shown reduced follicle loss and improved fertility outcomes at early reproductive age. However, the long-term effects on the competency of oocytes from such surviving follicles, compared to those at post-pubertal age, remain unknown. Small multiple CY (75 mg/Kg, four weekly doses) injections were administered to prepubertal (PP75X4) and adolescent (AD75X4) Swiss albino female mice. At 22 weeks of age, surviving females were assessed for follicular pool and oocyte functional competency. The resulting embryos were assessed for blastulation, total cell number (TCN) quality, and in vitro inner cell mass (ICM) progression. At 22 weeks of life, PP75X4 females had a three-fold reduction (p < 0.001) in the total number of follicles compared to the untreated control. However, the differences between PP75X4 and AD75X4 were not statistically significant. Though PP75X4 females demonstrated a significant (p < 0.001) reduction in oocyte yield when compared to AD75X4, embryo quality, blastulation, TCN, and apoptosis were comparable between PP75X4 and AD75X4 groups. Small multiple doses of CY lead to reduced oocyte yield in prepubertal mice compared to adolescents. This study suggests that oocytes from prepubertal and adolescent individuals receiving small multiple doses of CY exhibit comparable functional competence, resulting in embryos of similar quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.